![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
13 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control JAMA Ophthalmology Author Interviews
-
- Medicine
Interview with Michael X. Repka, MD, MBA, author of Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. Hosted by Neil Bressler, MD.
Related Content:
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control
Interview with Michael X. Repka, MD, MBA, author of Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. Hosted by Neil Bressler, MD.
Related Content:
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control
13 min
More by JAMA Network
JAMA Clinical Reviews
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
Coronavirus (COVID-19) Q&A
JAMA Network
JAMA Network Open Conversations
JAMA Network
JAMAevidence Users' Guides to the Medical Literature
JAMA Network
JAMAevidence The Rational Clinical Examination
JAMA Network